Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study.

[1]  H. Hod,et al.  Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction , 2004, Circulation.

[2]  C. Lau,et al.  Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. , 2004, Journal of the American College of Cardiology.

[3]  P. Watkins,et al.  Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance , 2004, Circulation.

[4]  A. Kastrati,et al.  A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. , 2004, The New England journal of medicine.

[5]  P. Fontana,et al.  P2Y12 H2 Haplotype Is Associated With Peripheral Arterial Disease: A Case-Control Study , 2003, Circulation.

[6]  Kevin P. Bliden,et al.  Clopidogrel for Coronary Stenting Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity , 2003, Circulation.

[7]  M. Murata,et al.  Shear‐induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis , 2002, Clinical cardiology.

[8]  Deepak L. Bhatt,et al.  Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. , 2002, Journal of the American College of Cardiology.

[9]  S. Steinhubl,et al.  Uniform platelet activation exists before coronary stent implantation despite aspirin therapy. , 2001, American heart journal.

[10]  T. Nakano,et al.  Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. , 2001, American heart journal.

[11]  D. Baim,et al.  Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.

[12]  T. Nakano,et al.  Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention. , 2000, The American journal of cardiology.

[13]  D. Baruch,et al.  Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. , 1998, Blood.

[14]  J. Moake,et al.  Platelets and shear stress. , 1996, Blood.

[15]  J. Moake,et al.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin , 1988 .

[16]  J D Hellums,et al.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. , 1988, Blood.